两阶段分层设计,具有生存结果和预测生物标志物错误分类的调整
Yanping Chen1, Yong Lin2,3, Shou-En Lu2,3
1Global Biometrics and Data Sciences, Bristol Myers Squibb, Berkeley Heights, New Jersey, USA.
Statistics in medicine
|April 18, 2024
概括
这项研究引入了一种新的统计方法,用于在生物标志物状态被错误分类时准确分析临床试验数据. 该方法提高了生物标志物分层试验中生存结果分析的可靠性.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 生物标志物研究 生物标志物研究
背景情况:
- 生物标志物分层临床试验对于评估生物标志物的效用和临床终点至关重要.
- 生物标志物状态通常会因为不完善的测试或分类规则而导致错误,使分析复杂化.
- 现有的方法很难准确地解释在生存结果分析中的生物标志物错误分类.
研究的目的:
- 为生物标志物分层临床试验开发一个强大的统计方法,以解释生物标志物错误分类.
- 在存在预测生物标志物错误的情况下,为生存结果提供调整后的测试统计数据.
- 为了使这些设计中的复合和组件智能假设能够进行可靠的顺序测试.
主要方法:
- 为生存结果提出了两阶段分层设计,并对预测生物标志物错误分类进行了调整.
- 使用观察到的生物标记物层来推断真实生物标记物状态层,构建调整后的日志等级统计.
- 开发了基于调整后的逻辑等级统计数据的全局和组件智能假设的顺序测试.
- 针对性功率分析和I型错误率控制,使用设计阶段统计数据之间的相关性.
主要成果:
- 拟议的方法提供了调整后的日志等级统计数据,可以解释生物标志物在生存数据中的错误分类.
- 允许对总体和特定生物标志物相关假设进行顺序测试程序.
- 在提出的框架内证明了功率分析和I型错误控制的可行性.
结论:
- 开发的方法提供了一个统计学上合理的方法来处理分层生存试验中的生物标志物错误分类.
- 这种方法提高了临床试验结果的准确性和可靠性,特别是在生物标志物驱动的研究中.
- 这种方法适用于现实场景,正如非小细胞肺癌免疫疗法试验所示.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
01:15Assumptions of Survival Analysis
125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
01:24Kaplan-Meier Approach
135
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
135
01:20Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:09Censoring Survival Data
88
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
88